ArticleMolecular cancer therapeutics2022

Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma.

Gina M Castellano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.